What’s in the PD Pipeline? Gene and Cell Therapies

March 25, 2016




When:      Tuesday, April 5, 2016, 1:00 PM - 2:00 


To sign up go to:

http://event.netbriefings.com/event/pdeb/Live/pdpipeline/register.html

Are there new therapies on the horizon to help treat PD? In the search for more effective treatments, two promising areas of research are gene therapies and cell therapies. Learn more about the potential of these two types of experimental treatments by joining a one-hour online seminar led by PDF and Roger Barker, M.B.B.S, M.R.C.P, Ph.D., Professor of Clinical Neuroscience and Honorary Consultant, Neurology, University of Cambridge and Addenbrooke's Hospital.

Learning Objectives:

• Learn how cell-based therapies for Parkinson’s are designed to replace dopamine cells lost to the disease.
• Understand how gene therapies are designed to either rescue dopamine cells or produce dopamine more efficiently in the brain.
• Understand why neither approach is a cure, but how each might one day offer exciting ways to help people with Parkinson’s live better and reduce their other medications.

Faculty:

Roger Barker, M.B.B.S, M.R.C.P, Ph.D., is Professor of Clinical Neuroscience and Honorary Consultant, Neurology, University of Cambridge and Addenbrooke's Hospital in the United Kingdom.

Since setting up his own research group in 1997, Dr. Barker has run a laboratory investigating basic and clinical aspects of Parkinson’s disease. He has been involved in several clinical trials studying gene and cell-based therapies for people living with PD. Dr. Baker also currently coordinates a European Union funded transplant program for PD. In addition to publishing over 300 papers, he is Co­-Editor in Chief of the Journal of Neurology.

Dr. Barker completed his neurology training and obtained his doctorate in neural grafting at the University of Cambridge. He received additional training at Oxford University and St. Thomas Hospital.

http://event.netbriefings.com/event/pdeb/Live/pdpipeline/register.htm